The three largest shareholders who are registered with
As of
The Nomination Committee consists of the following members:
Anton van Troostenburg , appointed byCerbios-Pharma SA - Per Nilsson, appointed by Råsunda Förvaltning AB
Magnus Hedman , appointed byAurena Laboratories AB Fredrik Sjövall , Chairman of the Board, convener
No later than six weeks before the Annual General Meeting, the Nomination Committee shall submit proposals regarding: Chairman of the Meeting; Chairman, other Board members and any Deputy Board members; fees to the Chairman and other Board members; election of auditor and fee to auditor; and, where applicable, amendments to these instructions.
The Nomination Committee's proposal will be presented in the notice convening the Annual General Meeting 2022 and on the company's website, www.lipidor.se.
Shareholders who wish to submit proposals to
Information
The information was provided for publication through the office of the below contact person on 9th
For further information, please contact:
Telephone: +46 (0)70 645 08 75
Email: fredrik.sjovall@lipidor.se
Certified Adviser
Telephone: +46 (0)8 463 80 00
Email: certifiedadviser@penser.se
About AKVANO®
AKVANO® is an innovative water-free and sprayable technology for the formulation of drugs and is particularly suitable for local application to, for example, the skin. AKVANO® is made up of carefully selected lipids which, together with a volatile solvent, constitute carriers of selected active substances. By combining different lipids, AKVANO® can be optimized to achieve the desired function of active components in the formulation. When applied to the skin, the solvent evaporates, and a thin lipid layer is formed on the skin surface for effective release of the active substance.
About
https://news.cision.com/lipidor/r/lipidor-presents-nomination-committee,c3468486
https://mb.cision.com/Main/17081/3468486/1507449.pdf
(c) 2021 Cision. All rights reserved., source